OUTCOMES OF CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS WITH 10%<= AND > 10% BCR-ABL1 (IS) TRANSCRIPT LEVELS AFTER 3 MONTHS OF GENERIC IMATINIB TREATMENT

Baslar Z., Eskazan A. E., Ayer M., Kantarcioglu B., Demirel N., Aydin D., ...More

20th Congress of European-Hematology-Association, Vienna, Austria, 11 - 14 June 2015, vol.100, pp.439-440, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• Volume: 100
• City: Vienna
• Country: Austria
• Page Numbers: pp.439-440
• Istanbul University-Cerrahpasa Affiliated: No